144 results
Page 3 of 8
8-K
91rb vxr3d8zs0cp4q
6 Nov 20
Humanigen Announces Cooperative Research and Development Agreement with the Department of Defense to Develop Lenzilumab for COVID-19
9:05am
424B5
m85du
18 Sep 20
Prospectus supplement for primary offering
5:19pm
424B5
mua urlz7xoh25
15 Sep 20
Prospectus supplement for primary offering
7:15am
424B3
3z898c5ct 9oir1u7
17 Aug 20
Prospectus supplement
8:45am
DEF 14C
4gukhrj
14 Aug 20
Information statement
4:41pm
424B3
2iw 8dcd3io6ld
5 Aug 20
Prospectus supplement
5:06pm
PRE 14C
lp04d
3 Aug 20
Preliminary information
5:02pm
8-K
840ywbs4qyvvb
16 Jun 20
Regulation FD Disclosure
4:30pm
POS AM
jhgo1al6whiqe3e b3gc
23 Mar 20
Prospectus update (post-effective amendment)
5:24pm
424B3
a27 u25zt02p3
4 Dec 19
Prospectus supplement
4:49pm
D
f2cbs6fgk vjc
22 Nov 19
$20.49M in equity, sold $494.61K, 1 investor
4:35pm
8-K
EX-10.1
v0bnk88lr
12 Nov 19
Entry into a Material Definitive Agreement
5:28pm